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INTRODUCTION
Despite developments in interventional cardiology during
the last decade, chronic total occlusions (CTO) still remain
as one of the unresolved problems in percutaneous coronary
interventions (PCI) (Prasad et al., 2007). CTO prevalence is
high; approximately one-third of patients with significant
coronary artery disease on angiography has at least 1 CTO,
but only less than 10% of percutaneous revascularisations
are CTO interventions (Werner et al., 2009). CTO PCI is
performed infrequently, likely due to historically low proce-
dural success rates, technical complexity, high equipment
use and the potential for major procedural complications
(Shah, 2011). Although several studies have shown that
successful recanalisation of chronic total occlusion (CTO)
of the coronary arteries has been associated with improved
survival, improved left ventricular systolic function, re-
duced angina, avoidance of coronary artery bypass grafting,
and increased exercise capacity, the overall benefit of reca-
nalisation of CTO is still limited by the deficiency of pro-
spective randomised trials, properly powered for hard clini-
cal endpoints, comparing contemporary optimal medical
therapy with contemporary state of the art CTO recanalisa-
tion (Hoye et al., 2005).
The retrograde approach is a relatively novel technique of
PCI for CTO, which allows the advancement of a guide
wire in a coronary segment distal to occlusion through col-
lateral vessels. In 1990, the first report of a retrograde ap-
proach for CTO was published, in which the retrograde wire
crossing technique was applied via a degenerated saphenous
vein graft (SVG) (Kahn et al., 1990). Later septal collaterals
were considered to provide potential access for the retro-
grade approach. In 2005, Katoh and colleagues opened a
new era of retrograde CTO recanalisation with the Con-
trolled Antegrade and Retrograde subintimal Tracking
(CART) technique (Surmely et al., 2006). Different kinds of
retrograde techniques were introduced in the last years.
Novel techniques hold promise in the field of percutaneous
coronary intervention for CTO (Saito et al., 2008).
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Coronary artery chronic total occlusions (CTO) are common — approximately one-third of pa-
tients with significant coronary artery disease on angiography have at least 1 CTO. Invasive treat-
ment of these lesions still remain a major challenge for interventional cardiology due to their
complexity. Historically, success rates have improved to about 60–70% by using only the tradi-
tional antegrade approach. The results have dramatically improved during the last decade after
more widespread application of new retrograde techniques. The aim of our study was to review
and analyse single hospital experience in CTO invasive treatment and to evaluate the long-term
results. A total of 519 patients undergoing percutaneous coronary interventions (PCI) for CTO at
a single tertiary PCI centre (Rîga East University Hospital), were included in the study. The me-
dian age was 64 years (38–88), and 80% were male. The retrograde approach (RA) was used for
167 (32.2%) of the CTO PCI patients. The overall patient success rate was 81.3% and it in-
creased from 73.9% in 2007 to 95.2% in 2015 (p < 0.001). Mean patient observation time was
five years. Overall survival was found significantly better in patients group after successful CTO
PCI procedures (Long-rank test, p = 0.013).
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The first successful retrograde PCI of CTO in Rîga East
University Hospital was conducted in January 2007.
The aim of our study was to review 10-year data from a sin-
gle hospital on CTO PCI experience and compare CTO PCI
procedural parameters and treatment results using antegrade
and/or retrograde approaches.
MATERIALS AND METHODS
The study included all patients undergoing PCI for CTO at
a single tertiary PCI centre during 10 years — between
January 2007 and January 2016. A total of 9564 PCI proce-
dures were conducted in this period in our institution. 591
(6.17%) of them were CTO PCI, which was applied for 519
patients. Ten patients had 2 coronary arteries CTOs, for 49
patients more than one CTO PCI attempt was made. The
retrograde approach was used for 167 (32.2%) of all CTO
PCI patients.
A CTO lesion was defined as an obstruction of a coronary
artery with Thrombolysis in Myocardial Infarction (TIMI)
flow grade 0 with an estimated duration of at least three
months. The duration of the occlusion was determined by
the interval from the last episode of acute coronary syn-
drome consistent with the location of the occlusion or
proven by previous angiography.
Indications for performing CTO PCI were at least one of the
following: symptoms (angina), positive exercise test, ische-
mia. PCI was also performed for asymptomatic CTO pa-
tients after myocardial infarction in the non CTO area with
normal ECG and normal echo findings at CTO related area.
The J-CTO score was used for CTO complexity assessment.
This score is the sum of anatomical findings and previous
attempt results — predictors of procedure failure: blunt
stump, CTO length > 20 mm, presence of severe calcifica-
tion, proximal segment tortuosity, and previous attempt fail-
ure.
An attempt of using the retrograde approach was defined as
the introduction of a guide wire into the collateral channels
(CCs), which was connecting to the target CTO vessel distal
to the lesion. Length of the CTO was measured following
bilateral simultaneous coronary injections by visualising the
filling of both proximal and distal occluded artery.
Procedural success was defined as a successful guide wire
and balloon crossing with residual stenosis < 10% and
Thrombolysis in Myocardial Infarction grade 3 flow.
All patients were pretreated with aspirin and clopidogrel.
5000 units of Heparin was used at the beginning of every
procedure. Additional 2500 units of Heparin were injected
every hour. Activated clotting time (ACT) was not meas-
ured. No GP 2B3A receptor blockers used. Both femoral
punctures with 6–8 French (Fr) guiding catheter were used
commonly. In some cases a radial route was performed to-
gether with femoral approach. Only guiding catheters with
side holes were used.
The decision and technique used to perform a retrograde at-
tempt was based on operators discretion. If CTO lesion
morphology was unfavourable (i.e., blunt stump, ostial lo-
cation, side branch located exactly at the proximal cap of
CTO), with expected low success rate of an antegrade ap-
proach, or in a case of unsuccessful antegrade attempt(s) to
recanalise a CTO with connecting collaterals filling of the
distal part of the target vessel, the retrograde approach was
considered as a treatment option. The retrograde approach
technique evolved over time with growing operator experi-
ence and emergence of dedicated devices.
Patients were separated according to year when PCI was
performed, approach (antegrade or retrograde) and PCI re-
sults (successful or unsuccessful). Demographic and proce-
dural data were collected at the time of intervention. In-
hospital MACE (myocardial infarction, urgent revasculari-
sation, stroke or death) was documented at discharge. Post
discharge data was obtained by telephone follow up.
Statistical analysis was performed using IBM SPSS Statis-
tics for Windows, version 22.0. Continuous variables were
summarised as mean value ± standard deviation (SD) if nor-
mally distributed or as median value and interquartile range
(IQR) if data distribution was skewed. Unpaired two-sided
t-test and Mann-Whitney U tests were used to compare sub-
groups. Categorical variables were presented as proportions
and subgroups compared by a chi-square test (or chi-square
test for trends if applicable). Significance of differences in
overall survival between subgroups was tested by Kaplan-
Meier method and log-rank test. A Cox proportional hazard
model was used to adjust for potential confounders such as
age and sex; the results of the model were presented as haz-
ard ratio (HR) with 95% confidence intervals (CI). A p
value less than 0.05 was set to indicate statistically signifi-
cant differences.
RESULTS
A total of 519 patients undergoing PCI for CTO were in-
cluded. The median (IQR) age was 64 yrs (38–88), and 80%
(415) were male. A retrograde approach (RA) was used for
167 (32.2%) patients. Use of a retrograde approach (RA) in-
creased from 13% in 2007 to 51.3% in 2013 and decreased
to 40.5% in 2015 (Fig. 1, Table 1). The overall patient suc-
cess rate was 81.3% and it increased from 73.9% in 2007 to
95.2% in 2015 (p < 0.001) (Fig. 2).
Table 2 shows baseline demographic and angiographic
characteristics of CTO patients.
The target artery with CTO lesions included the left main
(two cases, 0.4%) right coronary artery (305 cases, 58.8%),
the left anterior descending artery (167 cases, 32.17%), and
the left circumflex artery (45 cases, 8.7%). A retrograde ap-
proach was used in 36.9% (n = 111) of RCA, 25.9% (n =
43) of LAD and 26.7% (n 12) of LCX cases.
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Follow up started on the date of procedure, ended at the day
of death or 1 June 2016. Mean patient observation time was
58.7 months (median 60.1 month).
We did not find significant differences in patient clinical
characteristics undergoing antegrade and retrograde, suc-
cessful and unsuccessful procedures, except regarding prior
coronary artery bypass grafting (CABG). In the retrograde
approach patient group, 23 (13.6%) had previous CABG,
compared to 21 (6.0%) of patients in the antegrade group
(p = 0.004). Median (IQR) CTO duration was similar in
both retrograde and antegrade groups — 12 (3–60) and 12
(5–36) months, respectively.
Patients with diabetes (insulin dependent and non-insulin
dependent) were 21.1% (n = 74) in the antegrade approach
group and 15.4% (n = 26) in the retrograde approach group
(p = NS).
The J-CTO score was calculated for all patients: 215
(41.4%) had J CTO score 0 and 263 (50.7%) had score 2–3,
and 41 (7.9%) of patients had score 4–5. A retrograde ap-
proach was used more frequently in complex cases. For less
complex CTO lesions (J-CTO score 0–1), a retrograde ap-
proach was used in 7.7% and 19.7% of cases, respectively,
for intermediate complex lesions (J-CTO score 2 and 3) in
30.3% and 52.9%, respectively, for very complex lesions
(J-CTO score 4) in 70.1% of cases (p < 0.001).
Septal collaterals were more frequently used as the retro-
grade access route (85.3%), but during the last two years
use of epicardial channels has increased.
The main reasons for failure in both groups (antegrade and
retrograde) was inability to cross the occlusion with a wire
(68.7% of all unsuccessful cases).
The total complication rate was 6.5%: 5.9% in the antegrade
patients group and 7.2% (p = 0.630) in the retrograde group.
Kaplan-Meier curves showed better overall survival in the
successful procedure group compared to the unsuccessful
group (Long-rank test, p = 0.013) (Fig. 3), but the method
used (antegrade or retrograde) did not have any effect on
survival (Fig. 4). In the retrograde procedure group, survival
was significantly better (p = 0.019) if the procedure was
successful. Similarly, there was a tendency of better sur-
vival in the case of success also among patients who under-
went an antegrade procedure, albeit it was not statistically
significant (p = 0.118) (Figs. 5–6).
Fig. 1. Antegrade and retrograde approach usage in
CTO PCI cases 2007–1015. CTO, chronic total oc-
clusions; PCI, percutaneous coronary interventions
T a b l e 1







2007 69 9 13.0
2008 100 20 20.0
2009 59 12 20.3
2010 66 26 39.4
2011 50 23 46.0
2012 51 24 47.0
2013 39 20 51.3
2014 43 18 41.9
2015 42 17 40.5
Total 519 167 32.2
CTO, chronic total occlusions; PCI, percutaneous coronary interventions
Fig. 2. Overall CTO PCI success rates 2007–2015.
CTO, chronic total occlusions; PCI, percutaneous
coronary interventions
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Success was associated with lower mortality (Cox regres-
sion: HR 0.59 (95%CI 0.39–0.90; p = 0.014). The success
of the procedure remained significant also after adjustment
for patient age, sex and method: HR 0.58 (95%CI
0.38–0.89; p = 0.012).
DISCUSSION
The true prevalence of a CTO in the general population is
unknown and not well studied. In a few older studies the
prevalence of CTO in patients undergoing coronary angi-
ography ranged between 10% and 52% depending on the
clinical profile of the patient being examined. Among pa-
tients who underwent coronary angiography because of sus-
pected coronary artery disease, CTO prevalence was 18%,
but in patients with angiographically significant coronary
artery disease it was 30% (Christofferson, 2005). CTO
prevalence was observed to be higher (54%) among patients
with a history of aortocoronary bypass graft (CABG) sur-
gery and lower (10%) among patients with acute coronary
syndrome undergoing primary PCI (Fefer, 2012).
Data from registries reveal striking variability between dif-
ferent centres and countries. For example, in Japanese cen-
tres CTO incidence was 19% and 61.2% of these cases were
treated percutaneously (Yamamoto et al., 2013), however in
North America, where CTOs are more frequent (29–33%),
only between 6% and 9% of patients were treated percuta-
neously (Srinivas et al., 2002).
Fig. 3. Survival after successful and unsuccessful CTO PCI retrograde
cases. CTO, chronic total occlusions; PCI, percutaneous coronary interven-
tions
Fig. 4. Survival after successful and unsuccessful CTO PCI antegrade
cases. CTO, chronic total occlusions; PCI, percutaneous coronary interven-
tions
T a b l e 2








Mean age (±SD) 63.4 (10.5) 63.3 (10.7) 64.1 (10.0) 0.501















Hypertension 434 (83.6%) 356 (84.4%) 78 (80.4%) 0.343
Dislipidemia 358 (69.0%) 298 (70.6%) 60 (61.9%) 0.093
Diabetes 100 (19.3%) 86 (20.4%) 14 (14.4%) 0.181
Prior MI 380 (73.2%) 303 (71.8%) 77 (79.4%) 0.128
Prior CABG 44 (8.5%) 34 (8.1%) 10 (10.3%) 0.473
Prior PCI 266 (51.3%) 205 (48.6%) 61 (62.9%) 0.011
CTO, chronic total occlusions; PCI, percutaneous coronary interventions;l MI, myocardial infarction; CABG, coronary artery bypass grafting
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In our study the percentage of CTO PCI procedures was
low — only 6.2% of all PCI. The number of CTO PCI pro-
cedures has decreased during the last years, mainly due to
more careful patient selection.
According to definition, CTOs are at least three month old
lesions. They are therefore always found in stable chronic
patients, with varying levels of symptoms. Patients with
acute coronary syndrome occasionally also have a CTO in
another, non culprit artery, and is therefore considered a
CTO.
Several studies showed that CTO patients are a high-risk
population with more traditional cardiovascular risk factors,
multivessel disease, history of MI and PCI (Fefer et al.,
2012; Grantham et al., 2009).
There is no doubt that treatment of CTO affecting an
ischemic myocardial area that causes symptoms, such as an-
gina, should improve patient symptoms by providing a
greater perfusion flow than that provided by collateral cir-
culation, as a consequence of opening the occluded artery
(Werner et al., 2006). In the FACTOR Trial (Flow Cardia
Approach to CTO Recanalization), 125 patients completed
the Seattle Angina Questionnaire at baseline and one month
after percutaneous coronary intervention (Grantham et al.,
2010). Successful CTO treatment in this trial was associated
with an improvement in the frequency of angina, physical
capacity and quality of life. However, this improvement
was only observed in previously symptomatic patients but
not in asymptomatic patients.
If a patient has angina (and therefore ischemia), the benefit
of CTO treatment is symptom relief. For patients without
angina, but with ischemia, the benefit is not symptomatic
and can be evaluated only in prognostic terms (Aziz et al.,
2007). There is not much evidence about the benefit of
CTO invasive treatment for non symptomatic patients. The
SWISSI II trail conducted in the late 1990s included asymp-
tomatic CTO patients with 1 or 2 coronary artery disease af-
ter myocardial infarction and inducible ischemia in an im-
aging test. The results showed significant reduction of
coronary events in the successful CTO PCI group during
long-term follow up (Erne et al., 2007).
The recent Clinical Outcomes Utilizing Revascularization
and Aggressive Drug Evaluation (COURAGE) trial, which
compared PCI with optimal medical therapy in stable coro-
nary disease, did not show a significant difference in mor-
tality or myocardial infarction between the two treatment
options. However, CTOs were not included in the COUR-
AGE trial (Boden et al., 2007).
Some older registries have reported that patients with com-
plete revascularisation have a better prognosis than those
with incomplete revascularisation, including the presence of
an untreated CTO (Hannan et al., 2006, Valenti et al.,
2008). The SCAAR (Swedish Coronary Angiography and
Angioplasty) Registry includes data from 2006 and 2010 on
23 342 patients with multivessel disease. Incomplete revas-
cularisation (IR) was defined as any non-treated significant
(60%) stenosis in a coronary artery supplying 10% of the
myocardium. IR at the time of hospital discharge in pa-
tients with multivessel disease undergoing PCI was associ-
ated with a high risk of recurrent 1-year adverse cardiac
events (Hambraeus et al., 2016).
Although CTO patients are common in clinical work, the
evidence for the current guidelines and clinical practice is
limited. According to the current European Society of Car-
diology (ESC) Revascularisation guidelines, CTO percuta-
neous revascularisation is considered in patients with myo-
cardial ischemia given myocardial segment and / or
symptoms associated with angina (II A, Class B level rec-
Fig. 5. Overall survival after CTO PCI antegrade and retrograde cases.
CTO, chronic total occlusions; PCI, percutaneous coronary interventions
Fig. 6. Overall survival after successful and unsuccessful CTO PCI cases.
CTO, chronic total occlusions; PCI, percutaneous coronary interventions
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ommendation) (Kolh et al., 2014). A Retrograde approach
is recommended as a class IIb recommendation level C, af-
ter an unsuccessful antegrade approach or as a starting
method for selected patients, without describing this patient
group (Kolh et al., 2014).
In our study indication for CTO PCI was at least one of the
following: symptoms (angina), positive exercise test, ische-
mia. We also performed PCI for asymptomatic CTO pa-
tients after myocardial infarction in a non-CTO area with
normal ECG and normal echo findings in the CTO-related
area. Of course, this does not fully comply with modern un-
derstanding about myocardial viability and ischemia, but for
several reasons modern myocardial viability examinations
in our hospital were not available until 2013 and the main
examination given for these patients was an exercise test.
Due to better patient selection the number of CTO PCI pro-
cedures in our hospital has decreased.
Until 2005, the success rates of operators experienced in
conventional CTO percutaneous coronary intervention
(PCI) techniques has remained unchanged (60–70%), which
is considerably lower than the success rates in non-
occlusive coronary artery disease (Ivanhoe et al., 1992).
Many techniques and devices (wires, microcatheters) have
been introduced into clinical practice to improve the effec-
tiveness of CTO revascularisation (Sumitsuji et al., 2011).
One of the most important and popular techniques is the ret-
rograde approach, nowadays widely used, and first de-
scribed in 1990 by Kahn and Hartzler (1990). The first re-
port of retrograde crossing via septal collaterals was
published in 2006, starting the modern era, rapidly evolving
with the introduction of specialised equipment (Surmely et
al., 2006).
Vast experience in CTO invasive treatment has been gained
in Japan. According to data from the Japan Retrograde
Summit registry (Yoshikawa et al., 2013), use of the retro-
grade method was 26.6% of all PCI CTO and rate of suc-
cess has reached 84.8%.
Slightly lower success rates appear in the Euro CTO Club
register, which is world’s largest. According to the data
from this register, during the period from year 2008 to
2012, a retrograde method was used in 16.5% of successful
procedures and the success rate reached 75% (Gallassi et
al., 2015).
In our study a retrograde approach was used in 32.2% of
cases with success rate 71%, which is comparable with data
from Euro CTO Club registry. Use of a retrograde approach
has decreased during the last two years, likely due to opera-
tor skill improvement and introduction of new technologies
for antegrade CTO crossing.
The goal of CTO PCI has always been to make life easier
for patients by reducing symptoms and improving prognosis
by reducing the number of major cardiovascular events.
Multi-register data shows that successfully undergone CTO
PCI improves patient prognosis (Mehran, 2011; Joyal,
2010). In our study, unfortunately, symptom evaluation of
patients was not carried out, but, comparing survival after
successful and unsuccessful CTO PCI, significantly better
results were observed in the successful patient group (Fig.
3). These results coincide with data obtained in our hospital
in 2013 in a shorter observation period (Kalnins et al.,
2013).











































(IQR), mm 20 (15–25) 20 (15–25) 20 (15–30) 0.017
Median CTO vessel
diameter IQR), mm 3.0 (3.0–3.5) 3.0 (3.0–3.5) 3.0 (3.0–3.5) 0.111
Average Mean
J-CTO score (±SD) 1.8 (1.2) 1.7 (1.2) 2.5 (1.0) < 0.001
Average Median
J-CTO score (IQR) 2 (1–3) 2 (1–3) 3 (2–3) < 0.001
Previous CTO PCI
attempt 114 (22.0%) 74 (64.9%) 40 (35.1%) < 0.001























CTO, chronic total occlusions; PCI, percutaneous coronary interventions;
IQR, interquartile range;
T a b l e 4









Complications 34 (6.5%) 21( 5.9%) 12 (7.2%) 0.630
T a b l e 5









Complications 34 (6.5%) 23 (5.4%) 10 (10.3%) 0.077
CTO, chronic total occlusions; PCI, percutaneous coronary interventions
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CONCLUSIONS
The main finding of this study was increased survival in pa-
tients with successful CTO opening for symptomatic and/or
ischemic patients and patients with CTO, but without pre-
vious myocardial infarction. Long-term outcome and sur-
vival after CTO PCI not only depends on the approach (an-
tegrade or retrograde), but depends on results of the
procedure.
The authors declare that there is no conflict of interests re-
garding the publication of this paper.
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HRONISKU TOTÂLU KORONÂRO ARTÇRIJU OKLÛZIJU REKANALIZÂCIJA, PIELIETOJOT PERKUTÂNO KORONÂRO
INTERVENCI — VIENA CENTRA 10 GADU PIEREDZE
Hroniskas totâlas koronâro artçriju oklûzijas (HTO) sastopamas vienai treðdaïai pacientu ar nozîmîgu koronâro sirds slimîbu. HTO invazîva
ârstçðana ir apgrûtinâta tâs sareþìîtîbas dçï. Pielietojot tradicionâlo anterogrâdo metodi, sekmîgo procedûru skaits nepârsniedz 60–70%.
Rezultâtus iespçjams ievçrojami uzlabot, lietojot jaunâkâs retrogrâdâs HTO rekanalizâcijas metodes. Pçtîjuma mçríis bija izanalizçt vienas
terciârâ lîmeòa slimnîcas desmit gadu pieredzi HTO invazîvâ ârstçðanâ un izvçrtçt ilgtermiòa rezultâtus. Pçtîjumâ tika iekïauti 519 pacienti.
To vidçjais vecums bija 64 gadi, un 80% no tiem bija vîrieði. Retrogrâdâ rekanalizâcijas metode tika pielietota 167 (32,2%) pacientiem.
Sekmîgo procedûra skaits pieaudzis no 73,9% 2007. gadâ lîdz 95,2% 2015. gadâ. Vidçjais pacientu novçroðanas laiks bija 4,5 gadi.
Statistiski labâka dzîvildze tika novçrota sekmîgi veikto procedûru pacientu grupâ (Long-rank test, p = 0,013).
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